Citations for
1KCNJ2, PPKCA
Characterization of a Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for the Study of Variant Pathogenicity: Validation of a KCNJ2 Mutation.
Gélinas R, El Khoury N, Chaix MA, Beauchamp C, Alikashani A, Ethier N, Boucher G, Villeneuve L, Robb L, Latour F, Mondesert B, Rivard L, Goyette P, Talajic M, Fiset C, Rioux JD.
Circ Cardiovasc Genet 10(5). pii: e001755. doi: 10.1161/CIRCGENETICS.117.001755. 2017
2KCNJ2, PPKCA
Characterization of a novel KCNJ2 sequence variant detected in Andersen-Tawil syndrome patients.
Scheiper S, Hertel B, Beckmann BM, Kääb S, Thiel G, Kauferstein S.
BMC Med Genet 18(1):113. doi: 10.1186/s12881-017-0472-x. 2017
3KCNJ2, PPKCA
An inwardly rectifying K+ channel is required for patterning.
Dahal GR, Rawson J, Gassaway B, Kwok B, Tong Y, Ptácek LJ, Bates E.
Development 139(19):3653-64. doi: 10.1242/dev.078592. 2012
4KCNJ2, PPKCA
Inhibition of Kir2.1 (KCNJ2) by the AMP-activated protein kinase.
Alesutan I, Munoz C, Sopjani M, Dërmaku-Sopjani M, Michael D, Fraser S, Kemp BE, Seebohm G, Föller M, Lang F.
Biochem Biophys Res Commun 408(4):505-10. Epub 2011 Apr 9. 2011
5KCNJ2, PPKCA
Golgi export of the Kir2.1 channel is driven by a trafficking signal located within its tertiary structure.
Ma D, Taneja TK, Hagen BM, Kim BY, Ortega B, Lederer WJ, Welling PA.
Cell 145(7):1102-15. 2011
6KCNJ2, PPKCA
A novel neuropsychiatric phenotype of KCNJ2 mutation in one Taiwanese family with Andersen-Tawil syndrome.
Chan HF, Chen ML, Su JJ, Ko LC, Lin CH, Wu RM.
J Hum Genet 55(3):186-8. Epub 2010 Jan 29. 2010
7PPKCA, KCNJ2
An andersen-Tawil syndrome mutation in Kir2.1 (V302M) alters the G-loop cytoplasmic K+ conduction pathway.
Ma D, Tang XD, Rogers TB, Welling PA.
J Biol Chem 282(8):5781-9. Epub 2006 Dec 13. 2007
8PPKCA, KCNJ2
Mutations of KCNJ2 gene associated with Andersen-Tawil syndrome in Korean families.
Choi BO, Kim J, Suh BC, Yu JS, Sunwoo IN, Kim SJ, Kim GH, Chung KW.
J Hum Genet 52(3):280-3. Epub 2007 Jan 9. 2007
9KCNJ2, PPKCA
Functional and clinical characterization of a mutation in KCNJ2 associated with Andersen-Tawil syndrome.
Lu CW, Lin JH, Rajawat YS, Jerng H, Rami TG, Sanchez X, DeFreitas G, Carabello B, DeMayo F, Kearney DL, Miller G, Li H, Pfaffinger PJ, Bowles NE, Khoury DS, Towbin JA.
J Med Genet 43(8):653-9. Epub 2006 Mar 29. 2006
10KCNJ2, PPKCA
Andersen's syndrome mutation effects on the structure and assembly of the cytoplasmic domains of Kir2.1.
Pegan S, Arrabit C, Slesinger PA, Choe S.
Biochemistry 45(28):8599-606. 2006
11KCNJ2, PPKCA
Short QT syndrome or Andersen syndrome: Yin and Yang of Kir2.1 channel dysfunction.
Schulze-Bahr E.
Circ Res 96(7):703-4. No abstract available. 2005
12KCNJ2, PPKCA
Loss-of-function mutations of the K(+) channel gene KCNJ2 constitute a rare cause of long QT syndrome.
Fodstad H, Swan H, Auberson M, Gautschi I, Loffing J, Schild L, Kontula K.
J Mol Cell Cardiol 37(2):593-602. 2004
13PPKCA, KCNJ2
Function, subcellular localization and assembly of a novel mutation of KCNJ2 in Andersen's syndrome.
Hosaka Y, Hanawa H, Washizuka T, Chinushi M, Yamashita F, Yoshida T, Komura S, Watanabe H, Aizawa Y.
J Mol Cell Cardiol 35(4):409-15. 2003
14KCNJ2, PPKCA
KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes.
Andelfinger G, Tapper AR, Welch RC, Vanoye CG, George AL Jr, Benson DW.
Am J Hum Genet 71(3):663-8. 2002
15KCNJ2, PPKCA
Novel KCNJ2 mutation in familial periodic paralysis with ventricular dysrhythmia.
Ai T, Fujiwara Y, Tsuji K, Otani H, Nakano S, Kubo Y, Horie M.
Circulation 105(22):2592-4. 2002
16PPKCA, KCNJ2
Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome).
Tristani-Firouzi M, Jensen JL, Donaldson MR, Sansone V, Meola G, Hahn A, Bendahhou S, Kwiecinski H, Fidzianska A, Plaster N, Fu YH, Ptacek LJ, Tawil R.
J Clin Invest 110(3):381-8. 2002
17KCNJ2, PPKCA
Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome.
Plaster NM, Tawil R, Tristani-Firouzi M, Canun S, Bendahhou S, Tsunoda A, Donaldson MR, Iannaccone ST, Brunt E, Barohn R, Clark J, Deymeer F, George AL Jr, Fish FA, Hahn A, Nitu A, Ozdemir C, Serdaroglu P, Subramony SH, Wolfe G, Fu YH, Ptacek LJ.
Cell 105(4):511-9. 2001